During this partnering and investor conference, Swiss and Nordic biotech, pharmaceutical and medtech companies as well as investors meet in one-to-one meetings and present themselves in plenum.
Swiss Scandinavian Bio-Business Seminar has changed name to Swiss Nordic Bio and the 2017 event will take place at SIX Stock Exchange building in Zurich on February 8th.
The goal of the conference and by means of the Swiss-Nordic focus is to establish new contacts and networks. Previous events have gathered more than 170 participants and in nearly 50 percent of the matchmaking meetings, further contact was planned or cooperation considered.
The Swiss Nordic Bio is organized by the Nordic countries in cooperation with Swiss partners carries the tradition of 10 years of Swiss Scandinavian Bio-Business Seminar.
The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations.
The conference is open for biotech and pharma companies as well as investors within the life science industry. For other types of companies other conditions apply (e.g. participation fee for business services providers is 2000 CHF), please contact the Swiss Nordic Bio organization at firstname.lastname@example.org or +43 1 402 35 15 25.
Jan 20 – End of registration
Jan 4 – Feb 1 – Booking of one-to-one meeting
Feb 8 – Conference and one-to-one meetings